Glutamic acid decarboxylase (GAD) based delivery system
US6780409B2 · kind B2 · utility
7Cited by
3References
14Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | May 23, 2001 |
| Grant date | Aug 24, 2004 |
| Priority date | — |
| Expiry date | Oct 21, 2021 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2750/14143
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention provide methods and compositions for localized delivery of a vector comprising a therapeutic agent to a specific region of the brain that is overstimulated in neurodegenerative diseases. In particular, the invention provides methods and compositions used to deliver an adeno-associated virus vector (AAV) comprising a nucleotide sequence encoding glutamic acid decarboxylase (GAD) to cells in the subthalmic nucleus of the basal ganglia, mesaphilia and thalmus.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.